Under the company's iNDiGO trial that is anticipated to conclude in 2017, the patients will be randomised to receive either continuous subcutaneous infusion
of ND0612L or a placebo replaced every 24 hours during the 16-week treatment period.
Remodulin may be administered as a continuous subcutaneous infusion
or continuous intravenous infusion; however, because of the risks associated with chronic indwelling central venous catheters, including serious blood stream infections, continuous intravenous infusion should be reserved for patients who are intolerant of the subcutaneous route, or in whom these risks are considered warranted.
Remodulin is already cleared in most European countries for the continuous subcutaneous infusion
treatment of idiopathic or heritable PAH to improve exercise tolerance and symptoms in patients classified as New York Heart Association (NYHA) functional class III.
The advantages of continuous subcutaneous infusion
of insulin analogs in critically ill patients are to be determined.
Continuous subcutaneous infusion
of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension.
Contract notice: Supply of the necessary elements for the continuous subcutaneous infusion
of insulin, and for the interactive continuous monitoring systems of active glucose for the diabetes treatment program of the centers attached to the Platform of Health Logistics of Seville.
In the planned clinical trial, cenderitide will be delivered to heart failure patients for up to 24 hours through continuous subcutaneous infusion
. Nile said it expects to complete the trial by the first quarter of 2012.
Contract notice: Supply system for continuous subcutaneous infusion
of insulia with or without continuous monitoring glycemia for osi bilbao basurto.
"We also expect to hear stakeholder feedback on whether certain insulin products--for example, those that use insulin pumps for continuous subcutaneous infusion
among the approved uses--raise unique scientific considerations that we should be considering when evaluating biosimilar or interchangeable insulin products.
framework agreement for the supply of necessary elements for the continuous subcutaneous infusion
of insulin to two health centers in the province of mlaga belonging to sas.